$Semler Scientific (SMLR.US)$🎯 2024.4.9 The current price i...

New data: 23Q4. Revenue continued to grow, operating profit shrank by 26.5% due to a decline in gross margin, and net profit increased by 31.3% due to income tax rebates.

In 2023, revenue increased by 20.3%, operating profit increased by 33.6%, and net profit increased by 43.7%. The average net profit growth rate in the 3 years since listing was 13.7%.

The balance ratio fell from 11.2% to 8%, and both total assets and net assets increased. Cash and accounts receivable on the asset side are growing rapidly, current liabilities on the debt side have declined, and there are no interest-bearing liabilities.

Currently, the price-earnings ratio is 11, which is a clear discount compared to the growth rate. Considering that the current revenue scale is still very small, you can choose carefully (⭐️)